Your browser doesn't support javascript.
loading
Congenital polyvalvular disease expands the cardiac phenotype of the RASopathies.
Matalon, Dena R; Stevenson, David A; Bhoj, Elizabeth J; Santani, Avni B; Keena, Beth; Cohen, Meryl S; Lin, Angela E; Sheppard, Sarah E; Zackai, Elaine H.
  • Matalon DR; Division of Medical Genetics, Stanford University, Stanford, California, USA.
  • Stevenson DA; Division of Medical Genetics, Stanford University, Stanford, California, USA.
  • Bhoj EJ; Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Santani AB; Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Keena B; Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Cohen MS; Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Lin AE; Medical Genetics, MassGeneral Hospital for Children, Boston, Massachusetts, USA.
  • Sheppard SE; Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Zackai EH; Division of Human Genetics and Molecular Biology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Am J Med Genet A ; 185(5): 1486-1493, 2021 05.
Article en En | MEDLINE | ID: mdl-33683002
ABSTRACT
The RASopathies are a group of similar genetic syndromes with cardiovascular abnormalities, characteristic facial features, short stature, abnormalities of the skin and musculoskeletal system, and variable neurodevelopmental challenges. The most common cardiovascular abnormalities include pulmonary valvular stenosis and hypertrophic cardiomyopathy. Congenital polyvalvular disease (CPVD) refers to congenital dysplasia of two or more cardiac valves. We diagnosed a RASopathy in two individuals with CPVD and noted that CPVD in RASopathies has rarely been reported in the literature. Thus, we performed a retrospective chart review and literature review to investigate the association and characterize the phenotype of CPVD in the RASopathies. CPVD was present in 2.5% (n = 6/243) of individuals in our RASopathy cohort. Involvement of two cardiac valves, commonly the aortic and pulmonic valves, was seen in the majority of individuals (6/8; 75%) in our cohort, but only 27% (3/11) of reported CPVD and RASopathy cases in the literature. CPVD should be considered an associated cardiovascular phenotype of the RASopathies, which has implications for diagnosis and management.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estenosis de la Válvula Pulmonar / Cardiomiopatía Hipertrófica / Proteínas Proto-Oncogénicas B-raf / Proteína Tirosina Fosfatasa no Receptora Tipo 11 Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estenosis de la Válvula Pulmonar / Cardiomiopatía Hipertrófica / Proteínas Proto-Oncogénicas B-raf / Proteína Tirosina Fosfatasa no Receptora Tipo 11 Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Año: 2021 Tipo del documento: Article